Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > looking at one dollar 2023.

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Apr 25, 2023 3:23pm

57 Views

Post# 35413068

RE:looking at one dollar 2023.

I know that actors that has used Botox in the face now have trouble getting certain roles.

Would be pretty easy to get traction if they manage to spin the results in a Hollywood magazine. I'm convinced that we would see 1+ dollar tomorrow already as this is the holy grail.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec